As DUSP1 inhibition would utilize a different mechanism to kill cancer cells than traditional chemotherapies, combination therapies involving DUSP1 inhibition may reduce drug resistance and improve tumor regression.165. This evidence concerns the gene DUSP1 and neoplasm.